P1552: A PHASE 2, OPEN-LABEL STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFECT OF ANX005 IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA AND EVIDENCE OF COMPLEMENT ACTIVATION

Detalles Bibliográficos
Autores principales: Jaeger, U., Broome, C., Go, R., Patriarca, A., Roeth, A., Chang, Q., Weedin, N., Adams, P., Cahir-McFarland, E., Kroon, H.-A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429239/
http://dx.doi.org/10.1097/01.HS9.0000849064.31599.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429239/
http://dx.doi.org/10.1097/01.HS9.0000849064.31599.55

Ejemplares similares